GenNext Technologies specializes in advanced methodologies for protein higher-order structural (HOS) analysis, particularly through their proprietary Hydroxyl Radical Protein Footprinting (HRPF) technology. Their flagship product, the Fox® Protein Footprinting System, utilizes hydroxyl radicals to assess the solvent accessibility of amino acid side chains in proteins. This technique allows researchers to gather critical insights into protein structure and dynamics, which are essential for the development of safe and effective biopharmaceuticals. The system is designed to be user-friendly and integrates seamlessly into laboratory workflows, providing high-resolution data that can inform various aspects of biopharmaceutical research, including protein interactions, folding, and aggregation.

In addition to the Fox System, GenNext has introduced the AutoFox® Protein Footprinting System, which offers fully automated HRPF capabilities, eliminating the need for complex and costly laser systems. This innovation, combined with their FoxWare® software for data analysis, streamlines the process of HOS analysis, making it more accessible for researchers. GenNext's collaboration with SCIEX further enhances their offerings by integrating mass spectrometry technologies, allowing for comprehensive structural characterization of biotherapeutics. This partnership aims to improve the efficacy and safety of drug development, ultimately contributing to advancements in human health through better therapeutic solutions.

United States

GenNext Technologies makes structural biology easy by providing instrumentation, software, and services to pharmaceutical researchers investigating biopharmaceutical structure, interactions, folding, aggregation, formulation, and delivery. Our disruptive products are aimed at improving structural biology-focused research. Ultimately, we help our customers accelerate biopharmaceutical development, while improving therapeutic efficacy and safety.

GenNext Technologies

Company Details